Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA OTC monograph actions

This article was originally published in The Tan Sheet

Executive Summary

Final rules on the monographs for internal analgesics and skin protectant products among significant agency actions that appear closest to release, based on the FDA unified agenda published in the April 27 Federal Register. The agency estimates June publication of the two final rules. Final action on professional labeling for internal analgesics also is targeted for June. The agenda lists April dates for final action on sodium phosphates in laxatives and for a proposed amendment on phosphate labeling for laxatives. Other action that appears to be nearing completion includes a final rule on an amendment on sodium bicarbonate in antacids (slated for August), a proposed warning for antitussive cough/cold products (August) and final action on a warning for overindulgence products (August). Dates in the semiannual agenda are rough estimates and often change...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088415

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel